Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025)
Dianthus Therapeutics (DNTH) posted FCF Margin of -7717.17% for Q3 2025, down 6736.88 percentage points from -980.29% a year earlier but up 4685.94 percentage points from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, FCF Margin at Dianthus Therapeutics was -3561.63%, down 2393.65 percentage points year-over-year; for FY2024, it was -1255.57%, up 52.67 percentage points from FY2023.
- In prior years, Dianthus Therapeutics' FCF Margin was -1308.24% in FY2023 (-1080.35 pp) and -227.89% in FY2022.
- Quarterly FCF Margin has run from a low of -12403.11% in Q2 2025 to a high of 1399.91% in Q3 2022 over five years.
- On a year-over-year basis, FCF Margin has declined in each of the last three quarters, with an average year-over-year change of -2758.50 percentage points over the last eight quarters.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2024, with a gain of 524.04 percentage points; the weakest was Q2 2025, with a drop of 11622.38 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -12403.11% (Q2 2025), -2377.82% (Q1 2025) and -2072.02% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Dianthus Therapeutics | 3.74 Bn | 3.68 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -7,717.17% |
| Jun 30, 2025 | -12,403.11% |
| Mar 31, 2025 | -2,377.82% |
| Dec 31, 2024 | -2,072.02% |
| Sep 30, 2024 | -980.29% |
| Jun 30, 2024 | -780.73% |
| Mar 31, 2024 | -1,713.16% |
| Dec 31, 2023 | -2,596.06% |
| Sep 30, 2023 | -1,088.42% |
| Jun 30, 2023 | -241.34% |
| Mar 31, 2023 | -1,055.12% |
| Dec 31, 2022 | -117.23% |
| Sep 30, 2022 | 1,399.91% |
API Access
Dianthus Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();